Business Context and Reporting Period
Autolus Therapeutics Plc, a foreign private issuer, filed this Form 6-K on March 15, 2019. The filing serves to distribute the Company's UK Annual Report and Accounts for the fiscal year ended September 30, 2018, along with the Notice of Annual General Meeting and Form of Proxy.
Key Financial Metrics
The provided text is a cover filing and does not contain specific financial data. It references the UK Annual Report (Exhibit 1) as the source for revenue, profit, cash flow, margins, debt, and liquidity figures. Consequently, no numerical values for these metrics are available in this document.
Material Changes
The filing text does not provide comparative financial data or describe material changes versus prior periods. Such information is contained within the referenced UK Annual Report.
Guidance, Outlook, and Risks
This document does not include management commentary, forward-looking guidance, risk factors, or details on contingencies. It explicitly states that the information in the attached UK Annual Report is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 unless expressly incorporated by reference.
Investor Verification Checklist
- Review Exhibit 1 (UK Annual Report and Accounts) for actual financial performance data for the year ended September 30, 2018.
- Verify the date and agenda of the Annual General Meeting via Exhibit 2.
- Confirm the Company's status as a foreign private issuer filing under Form 20-F.
- Note that the financial details in the attached exhibits are not automatically incorporated by reference into this Form 6-K.